Cargando…
A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma
BACKGROUND: Methylprednisolone is recommended as the front-line therapy for radiation-induced brain necrosis (RN) after radiotherapy for nasopharyngeal carcinoma. However, some patients fail to benefit from methylprednisolone or even progress. This study aimed to develop and validate a radiomic mode...
Autores principales: | Zhuo, Xiaohuang, Zhao, Huiying, Chen, Meiwei, Mu, Youqing, Li, Yi, Cai, Jinhua, Li, Honghong, Xu, Yongteng, Tang, Yamei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979431/ https://www.ncbi.nlm.nih.gov/pubmed/36859353 http://dx.doi.org/10.1186/s13014-023-02235-2 |
Ejemplares similares
-
The correlation between serum apolipoprotein B/apolipoprotein A1 ratio and brain necrosis in patients underwent radiotherapy for nasopharyngeal carcinoma
por: Li, Honghong, et al.
Publicado: (2020) -
Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients
por: Cai, Jinhua, et al.
Publicado: (2022) -
Blood–Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study
por: Xue, Ruiqi, et al.
Publicado: (2021) -
Establishment and Validation of a Predictive Model for Radiation-Associated Aspiration Pneumonia in Patients with Radiation-Induced Dysphagia after Nasopharyngeal Carcinoma
por: Li, Honghong, et al.
Publicado: (2022) -
Bevacizumab Combined with Corticosteroids Does Not Improve the Clinical Outcome of Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis
por: Li, Honghong, et al.
Publicado: (2021)